Branded pharmaceutical manufacturers from large to emerging are struggling to ensure patients can find pharmacies that are capable and willing of dispensing Gen Med non-specialty brands, which account for 8% of the prescriptions that flow out of the pharmacy. Home delivery and digital pharmacy have attempted to provide feasible solutions, but to date have been insufficient to address these mounting barriers to access. Join Daniel Landis and Katie Herrick from Blue Fin Group, an IntegriChain Company as they discuss these challenges in Part 1 of our 3 part webinar series on Optimizing Physical Access and Affordability Challenges for Branded Rx Products - Meeting a $35 Patient Out-of-Pocket Target. Register today. https://bit.ly/3W5tzn1
IntegriChain’s Post
More Relevant Posts
-
I think this is an important topic of discussion. Branded medications are an important part of the pharmacy ecosystem that, like much else, feels broken. The economics often don't work for pharmacies, manufacturers, payers/plan sponsors, or patients. That is why at OnPoint Pharmacy we work to leverage our relationships with manufacturers and providers to make sure patients are able to access the medications they need, at prices they can afford, and in a way that is more sustainable to the healthcare system.
Branded pharmaceutical manufacturers from large to emerging are struggling to ensure patients can find pharmacies that are capable and willing of dispensing Gen Med non-specialty brands, which account for 8% of the prescriptions that flow out of the pharmacy. Home delivery and digital pharmacy have attempted to provide feasible solutions, but to date have been insufficient to address these mounting barriers to access. Join Daniel Landis and Katie Herrick as they discuss these challenges in Part 1 of our 3 part webinar series on Optimizing Physical Access and Affordability Challenges for Branded Rx Products - Meeting a $35 Patient Out-of-Pocket Target. Register today. https://bit.ly/3W5tzn1
To view or add a comment, sign in
-
Branded pharmaceutical manufacturers from large to emerging are struggling to ensure patients can find pharmacies that are capable and willing of dispensing Gen Med non-specialty brands, which account for 8% of the prescriptions that flow out of the pharmacy. Home delivery and digital pharmacy have attempted to provide feasible solutions, but to date have been insufficient to address these mounting barriers to access. Join Daniel Landis and Katie Herrick as they discuss these challenges in Part 1 of our 3 part webinar series on Optimizing Physical Access and Affordability Challenges for Branded Rx Products - Meeting a $35 Patient Out-of-Pocket Target. Register today. https://bit.ly/3W5tzn1
To view or add a comment, sign in
-
There's a way to digitalize prescribing efficiently with electronic prescription transformation. The Central e-Prescription does just that: it combats fake prescriptions in real-time, provides accurate pharmaceutical information for electronic prescriptions and ensures clinical decision-support alerts. It reinforces the prescribing ecosystem by digitally linking pharmacies and healthcare professionals to ensure efficient pharmaceutical distribution and improve healthcare quality. Discover our system designed to shape the future of prescription management! For detailed information: https://lnkd.in/dCcs_SmK #Tiga #HealthcareIT #PharmaIT #ePrescription
Central e-Prescription
To view or add a comment, sign in
-
Struggling with visibility into the prescription journey for specialty products? Pharmaceutical manufacturers face hurdles in understanding competitor data and brand performance. EVERSANA's Rx Benchmarks changes the game with double-blinded research involving 350+ pharmacists, delivering critical insights for successful specialty product access. Watch our short video to uncover how we provide crucial visibility for healthcare providers and patients and check out our article, “Benchmarking Your Specialty Brand’s Rx Pull-Through Against Competitors In and Out of Your Network”. #SpecialtyPharma #RxInsights #HealthcareAccess LEAR MORE AND WATCH THE VIDEO: https://ow.ly/1PxP50QpgAm
To view or add a comment, sign in
-
Another transformative tool from EVERSANA as we stay true to our commitment to improve global healthcare for all one patient at a time. RxBenchmarks follows that script from the MD pad to the patient and calls out any pain points along its journey. Let’s connect and let’s put this powerful tool to optimize your own specialty script journey.
Struggling with visibility into the prescription journey for specialty products? Pharmaceutical manufacturers face hurdles in understanding competitor data and brand performance. EVERSANA's Rx Benchmarks changes the game with double-blinded research involving 350+ pharmacists, delivering critical insights for successful specialty product access. Watch our short video to uncover how we provide crucial visibility for healthcare providers and patients and check out our article, “Benchmarking Your Specialty Brand’s Rx Pull-Through Against Competitors In and Out of Your Network”. #SpecialtyPharma #RxInsights #HealthcareAccess LEAR MORE AND WATCH THE VIDEO: https://ow.ly/1PxP50QpgAm
Rx Benchmarks® | EVERSANA
To view or add a comment, sign in
-
These days, all the savviest businesses rely on some form of automation to save time and money; the pharmaceutical industry is no exception. Automation is a game-changer for long-term care (LTC) pharmacies. In case you missed it, catch up on your blog reading with this informative guide to pharmacy automation. Read now: https://bit.ly/3PEJ3ed
To view or add a comment, sign in
-
Patients and employers who bear the inflated costs of prescription medications rarely see the full benefit of traditional pharmaceutical rebates. NuPrice is a radically unique solution in the marketplace built on a foundation of unmatched independence, transparency and truth. The result? Our ability to deliver lower out-of-pocket costs directly to the patient, greater savings to the health plan and improved outcomes across the pharmacy spectrum. Learn more at https://lnkd.in/e9GRt3fx
To view or add a comment, sign in
-
A Flat Monthly Membership Equals Free Prescriptions For Everyone! A Partnership That Powers Success: We have forged a powerful alliance with an industry-leading Pharmaceutical Distribution Company, renowned for its impeccable record of delivering prescriptions directly to consumers. By combining their logistical prowess with our robust marketing, sales, and commission systems, we're poised to hit a grand slam. Unlock the Features of DAC FlatFeeRx Here > https://lnkd.in/g3sbuxh6 - One Low Monthly Fee: Customers pay a single, affordable monthly fee to receive all their prescriptions "FREE". This includes most all prescriptions available. - Extended Savings: Beyond prescriptions, the program offers significant discounts on diabetes medications and over-the-counter drugs, broadening the scope of customer savings. - Revolutionizing Distribution: DAC FlatFeeRx is poised to disrupt the traditional pharmaceutical distribution model, offering an innovative approach that's unparalleled in the industry.
To view or add a comment, sign in
-
Take control of your pharmacy cost with Integra! Don't miss out on any pharmacy cost savings! Get started now and cut your pharmaceutical costs with our comprehensive technology solution. Visit our website to learn more integrascripts.com #savings #smartmoney
To view or add a comment, sign in
-
Silicon Review recognizes Medvantx as one of the top 5 healthcare companies to watch. At Medvantx, we bridge the gap between patients and essential medications, offering various programs and support for prescription assistance. Read more, as CEO of Medvantx, Prasanna talks about our innovative solution for patients, healthcare providers and pharmaceutical manufacturers: https://bit.ly/477Uu4G #HealthcareInnovation #MedicationManagement #Medvantx #SiliconReview
To view or add a comment, sign in
74,675 followers